ijddr

International Journal of Drug Development and Research

ISSN - 0975-9344

- (2013) Volume 5, Issue 3

View PDF Download PDF

Development and Optimization of Elementary osmotic pump tablet of Nicardipine Hydrochloride using central composite experimental Design

 

Author info »

Abstract

Elementary Osmotic Pumps (EOP) consists of osmotic core (coated with a semipermeable membrane (SPM) and a small orifice is created in the membrane. The objective of the present study was to develop an optimized EOP tablets containing inclusion complex of Nicardipine Hydrochloride (NH) using central composite design. Amount of osmotic agent (X1) and size of delivery orifice (X2) were selected as independent variables. Formulations were prepared by direct compression method and evaluated for % Cumulative Drug Release (% CDR) at 540min. as dependent variables. Amount of osmotic agent and size of delivery orifice had a significant effect on % CDR. The results of multiple linear regression analysis revealed that EOP tablets should be prepared using an optimum concentration of osmotic agent and size of delivery orifice to achieve a zero order drug release. Contour plots as well as response surface plots were constructed to show the effects of X1 and X2 on % CDR. A model was validated for accurate prediction of % CDR by performing checkpoint analysis. The computer optimization process, contour plots and response surface plots predicted at the concentration of independent variables X1 and X2 (50mg and 0.8mm respectively), for maximized response. The drug release from the developed formulation was found independent of pH and agitational intensity. The above optimized batch was also evaluated by different pharmacokinetic models. Stability study of optimized batch was conducted at accelerated conditions for six month and it was found to be stable.

References

  1. Verma RK, Garg S. Current status of drug delivery technologies and future directions. PharmaTechn. 2001; 25: 1–14.
  2. Verma RK, Divi MK, Garg S. Formulation aspects in the development of osmotically controlled oral drug delivery systems. J Cont Rel. 2002; 79: 7-27.
  3. Conley R, Gupta SK, Sathyan G. Clinical spectrum of the osmotic-controlled release oral delivery system (OROS), an advanced oral delivery form. Curr Med Res and Opinion. 2006; 22: 1879-1892.
  4. Wong PSL, Gupta SK, Stewart BE. Osmotically controlled tablets. In: Rathbone MJ, Handgraft J, Roberts MS (eds). Modified-Release Drug Delivery Technology, New York: Marcel Dekker Inc, pp 101- 114.
  5. Santus G, Baker RW. Osmotic drug delivery: a review of the patent literature. J Cont Rel. 1995; 35: 1–21.
  6. Theeuwes F. Elementary osmotic pump. J Pharm Sci. 1975; 64: 1987–1991.
  7. Swanson DR, Barclay BL, Wong PSL, Theuwes F. Nifedipine gastrointestinal therapeutic system. American J Med. 1987; 83: 3-9.
  8. Wong PSL, Barclay BL, Deters JC, Theeuwes F. Osmotic device for administering certain drugs. US Patent 4,765,989. 1986.
  9. Grundy JS, Foster RT. The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties. Clin. Pharmacokinet. 1996; 30(1): 28-51.
  10. Geerke JH. Method and apparatus for forming dispenser delivery ports. US patent 5,658,474. 1997.
  11. Herbig SM, Cardinal JR, Korsmeyer RW, Smith KL. Asymmetric membrane tablet coating for osmotic drug delivery. J Cont Rel. 1995: 35: 127–136.
  12. Chiou WL, Riegelman S. Pharmaceutical application of solid dispersion systems. J Pharma Sci. 1971; 60: 1281–1302.
  13. Okimoto K, Rajewski RA, Stella VJ. Release of testosterone from an osmotic pump tablets utilizing (SBE)7m-ß-CD as both a solubilizing and an osmotic pump agent. J Cont Rel. 1999; 58: 29–38.
  14. NilfiferYfiksel, TeomanTinger, Tamer Baykara. Interaction between Nicardipine hydrochloride and polymeric microspheres for a controlled release system. Int J Pharm. 1996; 140: 145-154.
  15. Pao-Chu Wu, Yaw-Bin Huang, Chia-Hung Sung, Ren-Jiunn Wang, Yi-Hung Tsai. The effect of Eudragit and enteric polymer composite on the release of Nicardipine. J Food Drug Anal. 2006; 14(4): 334-339.
  16. Kanagale P, Patel V, Venkatesan N, Jain M, Patel P, Misra A. Pharmaceutical development of solid dispersion based osmotic drug delivery system of nifedipine. Curr Drug Del. 2008, 5: 306-311.
  17. Shah TJ, Amin AF, Parikh JR, Parikh RH. Process optimization and characterization of poloxamer solid dispersions of a poorly water-soluble drug. AAPS PharmSciTech. 2007, 8(2): E1-E7.
  18. Mehramizi A, Alijani B, Pourfarzib M, Dorkoosh FA, Tehrani MR. Solid carriers for improved solubility of glipizide in osmotically controlled oral drug delivery system. Drug DevInd Pharm. 2007, 33: 812-823.
  19. En-Xian Lu, Zhi-Qiang Jiang, Qi-Zhi Zhang, Zin-Guo Jiang. A water insoluble drug monolithic osmotic tablet system utilizing gum Arabic as an osmotic, suspending and expanding agent. J Cont Rel. 2003, 92: 375-382.
  20. Roy H, Chakraborty A, Nayak BS, Bhanja S, Mishra SR, Ellaiah P. Design and in vitro evaluation of sustained release matrix tablets of complexedNicardipine Hydrochloride. Int J Pharm Pharm Sci. 2010; 2(4): 128-132.

Author Info

 

Copyright:This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

iomcworld scan

Journal Highlights

Journal Flyer

Flyer